Overview

This trial is active, not recruiting.

Condition cancer
Sponsor Atrium Medical Center
Collaborator Maastricht University Medical Center
Start date November 2006
End date June 2015
Trial size 520 participants
Trial identifier NCT00704587, MEC 08-02-030, METC 06-p-47, NL14215.096.06, ProFaCo

Summary

The purpose of this study is to investigate every possible applicability of flow cytometrical analysis in the intracellular detection of tumor-related material in activated macrophages in the broadest range of cancer types.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective

Primary Outcomes

Measure
screening and followup
time frame: 2 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - (Suspicion of) presence of cancer in the broadest sense of the word - Must be able to understand and sign written informed consent Exclusion Criteria: - None

Additional Information

Official title Flow Cytometrical Analysis of the Human Immune System to Assess Tumor-related Material Piling up in Activated Macrophages in All Relevant Cancer Types.
Principal investigator Dennis Japink, MD
Trial information was received from ClinicalTrials.gov and was last updated in December 2014.
Information provided to ClinicalTrials.gov by Atrium Medical Center.